NeuroMetrix, Inc. (NURO): Price and Financial Metrics
NeuroMetrix, Inc. (NURO)
Today's Latest Price: $4.36 USD
Updated Jan 27 3:39pm
Add NURO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
NURO Stock Summary
- With a market capitalization of $18,847,592, NeuroMetrix Inc has a greater market value than only 5.5% of US stocks.
- Revenue growth over the past 12 months for NeuroMetrix Inc comes in at -35.59%, a number that bests merely 9.22% of the US stocks we're tracking.
- NeuroMetrix Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -22.07%, greater than the shareholder yield of merely 12.1% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to NeuroMetrix Inc, a group of peers worth examining would be XONE, HTGM, SRTS, SONM, and ULBI.
- NURO's SEC filings can be seen here. And to visit NeuroMetrix Inc's official web site, go to www.neurometrix.com.
NURO Stock Price Chart Interactive Chart >
NURO Price/Volume Stats
| Current price | $4.36 | 52-week high | $6.20 |
| Prev. close | $4.98 | 52-week low | $0.81 |
| Day low | $4.18 | Volume | 567,930 |
| Day high | $4.79 | Avg. volume | 605,886 |
| 50-day MA | $2.87 | Dividend yield | N/A |
| 200-day MA | $2.21 | Market Cap | 16.50M |
NeuroMetrix, Inc. (NURO) Company Bio
NeuroMetrix Inc. is a medical device company that designs, develops and sells proprietary products used to diagnose neuropathies. The Company's neuropathy diagnostic system provides primary care and specialist physicians objective information that aids in the diagnosis of neuropathies at the point of service.
Loading social stream, please wait...